Results 191 to 200 of about 1,118,251 (356)
Objective This study assessed sarilumab in treating patients with polyarticular‐course juvenile idiopathic arthritis (pcJIA). Methods This phase 2b, open‐label study (NCT02776735) consisted of three sequential parts (each with a core‐treatment and extension‐phase). During part 1, three doses were assessed in two weight groups (Group A/B: ≥30–60 kg/≥10–<
Fabrizio De Benedetti +19 more
wiley +1 more source
Complete blood count reference intervals for extremely preterm neonates. [PDF]
Wolfsberger CH +7 more
europepmc +1 more source
Objective A patient‐centered approach for chronic disease management, including systemic lupus erythematosus (SLE), aligns treatment with patients’ values and preferences, leading to improved outcomes. This paper summarizes how patient experiences, perspectives, and priorities informed the American College of Rheumatology (ACR) 2024 Lupus Nephritis (LN)
Shivani Garg +20 more
wiley +1 more source
Predicting malaria in sudanese pregnant women: reliability of complete blood count. [PDF]
Dura MC +5 more
europepmc +1 more source
Reference values for blood parameters in complete blood count analysis.
Daniel Walke (21680915) +7 more
openalex +1 more source
Normal complete blood count reference intervals in the Turkish population: a prospective study [PDF]
Emine Aygör Kabasakal +2 more
openalex +1 more source
Objective This study aimed to characterize the pharmacokinetics, pharmacodynamics, safety, and exploratory efficacy of subcutaneous belimumab in pediatric patients with active systemic lupus erythematosus (SLE) receiving standard therapy. Methods This single‐arm, multicenter, open‐label trial (GSK study 200908; NCT04179032) used three‐weight‐band ...
Hermine I. Brunner +14 more
wiley +1 more source
A Multicenter Study on the Prognostic Value of Indicators Derived From Complete Blood Count in Glioblastoma. [PDF]
Hou S +7 more
europepmc +1 more source

